Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS)

Historical Holders from Q2 2016 to Q2 2023

Symbol
SYRS on Nasdaq
CUSIP
87184Q107
Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
28M
All holders as of June 30, 2023
Q2 2023
Shares, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Invus Global Management, LLC 3.8% $777K 1.06M Invus Public Equities, L.P. Dec 31, 2024

Institutional Holders of Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2023 Q2 0 $0 -$585 0
2023 Q1 219 $585 $0 $2.67 1
2022 Q4 219 $786 -$5.68M $3.59 1
2022 Q3 882K $5.68M -$38.8M $6.44 3
2022 Q2 35.5M $34.1M -$9.58M $0.96 57
2022 Q1 40.4M $48M -$16.2M $1.19 84
2021 Q4 51.1M $166M +$3.04M $3.26 81
2021 Q3 50.1M $223M -$4.67M $4.47 94
2021 Q2 47.9M $260M -$112M $5.45 96
2021 Q1 60.9M $454M +$49.7M $7.48 98
2020 Q4 52.8M $571M +$86.5M $10.85 97
2020 Q3 46M $406M +$11.5M $8.84 90
2020 Q2 40M $425M +$6.98M $10.66 77
2020 Q1 44.9M $265M +$15.2M $5.93 63
2019 Q4 42.2M $291M -$5.24M $6.91 70
2019 Q3 39.2M $406M +$49M $10.38 60
2019 Q2 34.8M $321M +$102M $9.26 65
2019 Q1 23.8M $218M +$16.3M $9.14 63
2018 Q4 22.2M $124M +$988K $5.57 65
2018 Q3 20.6M $246M +$2.47M $11.91 74
2018 Q2 20.4M $209M +$16.5M $10.21 72
2018 Q1 18.5M $240M +$38.7M $12.98 54
2017 Q4 15.9M $154M +$4.66M $9.73 67
2017 Q3 12M $177M +$16.4M $14.72 64
2017 Q2 15.6M $251M +$43.7M $16.09 45
2017 Q1 12.9M $205M +$2.46M $15.93 41
2016 Q4 12.9M $157M +$1.76M $12.16 40
2016 Q3 12.8M $176M +$3.96M $13.87 34
2016 Q2 3.03M $37.8M +$37.8M $12.50 1